Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease melanoma, malignant
Comorbidity C0376358|prostate cancer
Sentences 6
PubMedID- 24742063 The higher rate of malignant melanoma among patients with breast and prostate cancer requires further investigation.
PubMedID- 25884238 The association of an increased risk for melanoma among patients with prostate cancer has been reported in cancer registry data in 2011 and 2012 [6,7].
PubMedID- 24563423 The association of an increased risk of developing melanoma in patients with prostate cancer has recently been confirmed.
PubMedID- 22661971 However, similar to the development of acquired resistance in melanoma patients treated with vemurafenib, most prostate cancer patients who initially respond to adt subsequently become refractory.
PubMedID- 21610321 Autophagy switches to apoptosis in prostate cancer cells infected with melanoma differentiation associated gene-7/interleukin-24 (mda-7/il-24).
PubMedID- 22822350 Kahalalide f which has shown antitumor activity [72] has recently undergone phase iii clinical trials for the treatment of lung and prostate cancers along with melanoma [76].

Page: 1